3SBio
Latest Rankings
- #9 in 2026 China Innovation View full results
- #19 in 2026 China Invention View full results
In the 2026 China PIII, 3SBio ranked 9th in Innovation and 19th in Invention. Its highlights for the year centered on the commercial translation of innovation: its mature product portfolio provides a stable operating foundation, while a major international licensing deal for its proprietary asset SSGJ-707 further expanded the ways in which it realizes innovation value and drove growth in operating results. At the same time, sustained R&D investment and late-stage pipeline progress provide a reserve for the company's future innovation translation.
2025 was a pivotal year in which 3SBio achieved a breakthrough in realizing the value of its innovative assets, with a major international licensing transaction driving its operating results to a record high...
Download the report to see the full company profile.
Download the report
The China Pharmaceutical Innovation and Invention Index, and the accompanying report, explore the performance of individual companies in much greater detail. By accessing our full report, you are given an inside look into our research and findings.
- 1 Methodology and analysis
- 2 Extended profiles of the Top 10 overall companies
- 3 The full top 30 ranking
- 4 The report in full